| Revision as of 18:10, 23 October 2007 editTruther truther (talk | contribs)430 editsNo edit summary← Previous edit | Revision as of 18:12, 23 October 2007 edit undoTwooars (talk | contribs)Extended confirmed users, Rollbackers3,767 editsm fix formattingNext edit → | ||
| Line 1: | Line 1: | ||
| '''Joseph Schlessinger''', Ph.D. is Chair of the Pharmacology Department at ] in New Haven, Connecticut. His area of research is ] ] which potentially plays a role in the treatment of several different types of cancer. | '''Joseph Schlessinger''', Ph.D. is Chair of the Pharmacology Department at ] in New Haven, Connecticut. His area of research is ] ] which potentially plays a role in the treatment of several different types of cancer. | ||
| ==Publcations== | |||
| ==Publcations== | |||
| ⚫ | |||
| ==SUTENT== | |||
| ⚫ | ==Yale University== | ||
| ==Other== | |||
Revision as of 18:12, 23 October 2007
Joseph Schlessinger, Ph.D. is Chair of the Pharmacology Department at Yale University in New Haven, Connecticut. His area of research is Tyrosine phosphorylation which potentially plays a role in the treatment of several different types of cancer.
Publcations
SUTENT
Yale University
Other
References
- Yale School of Medicine appoints Joseph Schlessinger, formerly of NYU, Pharmacology Chair., M2 Presswire, 05-JUN-01.
- YALE RESEARCHER SHARES $1 MILLION PRIZE
 | This biographical article about a scientist is a stub. You can help Misplaced Pages by expanding it. |